Member Info for Joshholdforgold

When £90m was raised in autumn last year there were no TR1s issued and I struggled to believe that many sub 3% stakeholders had come together. Where were the missing shares?

Well, I think that Numis may have had them. If this were not the case, I simply don’t think the MM would have had enough free float to sell 15m shares in auction this week.

It is also possible that Numis and FinnCap underwrote the placement, agreeing to sell them to institutional investors on completions of certain milestones, which Synairgen may just now be completing.

TR1s must be impending and my gut feeling is that Venrock are back.

GLA - exciting times to be a holder.

A note on underwriting share issues:

https://ebrary.net/860/economics/underwriting_shissue

https://www.nih.gov/news-events/news-releases/four-potential-covid-19-therapeutics-enter-phase-2-3-testing-nih-activ-2-trial

Activ 2 will be ready about the same time as home trials.

The big hope is that this will be beyond the tipping point for an EUA

Bettingman - there is one drug currently being trialed on Activ 2 which is BRIIs ****tail of antibodies. This is a 220 patient trial which began recruiting on the 5th.
I think we will have the spotlight thrust upon us very soon and we will get an NOH release when our trial starts.

BRII, who also have a drug on Activ 2 announced their inclusion on 18th December.

The NIH announced recruitment had begun on 5th Jan.

Using the same number of days between, which may be pre-agreed and standard, then A2 should be announcing and beginning this Friday.

This has been confirmed by my Crystal ball.

TornadoTony - I don’t mean this disrespectfully as I’ve valued your contributions to the board, not to mention the fact that your predictions have been very accurate, but why would you think that the chart can be used to determine the date of news?

Surely that is the wrong way around?

Good Luck Andy! I too have all my eggs in this basket, having originally invested in March and built my stake over the year since.

I came to the decision that I could re-build what I lost, if this falls apart through a lot of hard work, although it would be painful, but the potential upside is could be life changing and the odds of success seem extremely high for such a potential return.

I have promised myself that I will diversify and never again have more than 20% in one share after synairgen has run its course.

My guess: No RNS but intense buying continues up to the White House covid briefing at 4 when Fauci name drops synairgen. Buzz light year then flies into onto the White House lawn to fan fair and glory.

Or we see first patient in USA dosed for either P3 and A2.

Has there been an interview today which I have missed?

That’s a very useful. Firstly demonstrating the chances of pre-orders and secondly as a comparison for price point for Molnuplavir.

I heard a rumour he has been recruited by the KGB and they are now repurposing his skills.

Count me in!

On another board I saw a pub meet up organised. A few regulars just picked a pub in London and lots turned up.

I feel like you’d need name badges with your lse handle on it.

https://www.theguardian.com/world/2021/jan/19/single-covid-vaccine-dose-in-israel-less-effective-than-we-hoped?CMP=Share_AndroidApp_Other

If it was 52% effective and R in new normal was 1.6 then in theory R would drop to under 1 and it would be a gamble well made......but

New variant is more like R of 2.4, efficiency is less than 50% and vaccine uptake is not 100%

So R stays greater than 1. Pandemic continues to get worse.

Ou est le sng001?

Strictly it is only significant in so far as working out whether closing the short caused today’s rise.

If they are still short, they will very soon be buying £1m shares to close it out. That should see another 10 point rise before news.

Although I’d like to see Citadel caught with their pants down when activ2 lands.

Lloyds did it instantly for me. I imagine lots of other brokers do too. Call them and see. You don’t really want to be at risk of missing activ 2 announcement for 3 days!

With citadel having taken a short position of 0.51% the moronic de-rampers that have appeared over the weekend clearly work for Citadel.

The low quality of their comments is quite frankly an embarrassment and shows their lack of understanding of synairgen.

So run along children and tell your boss to get out before activ 2 lands, or else you are going to be on the naughty step!!

165p open and 174p close. Share price bolstered by Biden and a little Friday fomo given activ 2, full recruitment of home trials and possibly PROTECT trial inclusion are all imminent.

Great find. Again.
Our Activ 2 RNS can only be a maximum of 2 weeks away and could land any day between now and then. Fireworks at the ready.

Your rather than you’re in first comment was a typo not stupidity! I promise.